Further, differences in other characteristics such as Ki-67 and tumor size—potential determinants for a length bias (screening detects disproportionately more slowly growing tumors) [26]—could lead to an overestimation of the effectiveness of MSPs. Here, MKI67 is linked to neoplasm.